Mouwasat Medical Services Past Earnings Performance
Past criteria checks 3/6
Mouwasat Medical Services has been growing earnings at an average annual rate of 11.9%, while the Healthcare industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 8.6% per year. Mouwasat Medical Services's return on equity is 20.1%, and it has net margins of 24.3%.
Key information
11.9%
Earnings growth rate
11.9%
EPS growth rate
Healthcare Industry Growth | 12.3% |
Revenue growth rate | 8.6% |
Return on equity | 20.1% |
Net Margin | 24.3% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Dec 08Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Nov 24Revenue & Expenses BreakdownBeta
How Mouwasat Medical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 2,706 | 658 | 547 | 0 |
30 Sep 23 | 2,593 | 659 | 472 | 0 |
30 Jun 23 | 2,501 | 625 | 464 | 0 |
31 Mar 23 | 2,431 | 616 | 446 | 0 |
31 Dec 22 | 2,334 | 599 | 419 | 0 |
30 Sep 22 | 2,226 | 561 | 396 | 0 |
30 Jun 22 | 2,208 | 581 | 383 | 0 |
31 Mar 22 | 2,177 | 581 | 372 | 0 |
31 Dec 21 | 2,144 | 578 | 360 | 0 |
30 Sep 21 | 2,125 | 574 | 369 | 0 |
30 Jun 21 | 2,143 | 593 | 373 | 0 |
31 Mar 21 | 2,085 | 567 | 369 | 0 |
31 Dec 20 | 2,045 | 528 | 371 | 0 |
30 Sep 20 | 2,016 | 515 | 364 | 0 |
30 Jun 20 | 1,911 | 447 | 355 | 0 |
31 Mar 20 | 1,889 | 422 | 357 | 0 |
31 Dec 19 | 1,857 | 421 | 349 | 0 |
30 Sep 19 | 1,808 | 376 | 367 | 0 |
30 Jun 19 | 1,769 | 364 | 370 | 0 |
31 Mar 19 | 1,717 | 361 | 367 | 0 |
31 Dec 18 | 1,677 | 360 | 361 | 0 |
30 Sep 18 | 1,652 | 373 | 359 | 0 |
30 Jun 18 | 1,608 | 369 | 345 | 0 |
31 Mar 18 | 1,567 | 358 | 337 | 0 |
31 Dec 17 | 1,507 | 337 | 334 | 0 |
30 Sep 17 | 1,435 | 314 | 318 | 0 |
30 Jun 17 | 1,356 | 286 | 307 | 0 |
31 Mar 17 | 1,303 | 274 | 296 | 0 |
31 Dec 16 | 1,243 | 257 | 284 | 0 |
30 Sep 16 | 1,144 | 235 | 254 | 0 |
30 Jun 16 | 1,095 | 229 | 236 | 0 |
31 Mar 16 | 1,050 | 221 | 220 | 0 |
31 Dec 15 | 1,000 | 209 | 209 | 0 |
30 Sep 15 | 926 | 206 | 157 | 0 |
30 Jun 15 | 925 | 235 | 167 | 0 |
31 Mar 15 | 914 | 238 | 175 | 0 |
31 Dec 14 | 904 | 240 | 179 | 0 |
30 Sep 14 | 961 | 240 | 245 | 0 |
30 Jun 14 | 942 | 212 | 242 | 0 |
31 Mar 14 | 927 | 207 | 238 | 0 |
31 Dec 13 | 902 | 201 | 229 | 0 |
30 Sep 13 | 873 | 193 | 218 | 0 |
30 Jun 13 | 848 | 185 | 210 | 0 |
Quality Earnings: 4002 has high quality earnings.
Growing Profit Margin: 4002's current net profit margins (24.3%) are lower than last year (25.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4002's earnings have grown by 11.9% per year over the past 5 years.
Accelerating Growth: 4002's earnings growth over the past year (9.7%) is below its 5-year average (11.9% per year).
Earnings vs Industry: 4002 earnings growth over the past year (9.7%) did not outperform the Healthcare industry 20.5%.
Return on Equity
High ROE: 4002's Return on Equity (20.1%) is considered high.